DCF Advisers’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $41.7K | Sell |
|
|||||
|
2025
Q1 | $109K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $233K | Sell |
|
|||||
|
2024
Q2 | $285K | Sell |
|
|||||
|
2024
Q1 | $980K | Sell |
|
|||||
|
2023
Q4 | $1.3M | Sell |
|
|||||
|
2023
Q3 | $312K | Hold |
|
|||||
|
2023
Q2 | $424K | Buy |
|
|||||
|
2023
Q1 | $325K | Sell |
|
|||||
|
2022
Q4 | $1.33M | Sell |
|
|||||
|
2022
Q3 | $2.92M | Sell |
|
|||||
|
2022
Q2 | $3.92M | Buy |
|
|||||
|
2022
Q1 | $1.92M | Buy |
|
|||||
|
2021
Q4 | $2.57M | Buy |
|
|||||
|
2021
Q3 | $2.71M | Buy |
|
|||||
|
2021
Q2 | $1.44M | Buy |
|